Cell and Gene Therapies

Oct 15, 2018
By BioPharm International Editors
The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.
Oct 10, 2018
By BioPharm International Editors
The companies signed a three-year clinical manufacturing agreement to manufacture GlaxoSmithKline’s specific peptide enhanced affinity receptor T-cell receptor therapy for United States, Canadian, and European clinical trials.
Oct 10, 2018
By BioPharm International Editors
The companies will develop and commercialize ARO-HBV, a Phase I/II subcutaneous, ribonucleic acid interference therapy candidate being investigated for the treatment of chronic hepatitis B viral infection.
Sep 27, 2018
By BioPharm International Editors
GE Healthcare, Cobra Biologics, and the Centre for Process Innovation (CPI) have entered into a collaboration to advance manufacturing of adeno-associated virus vectors for gene therapy.
Sep 24, 2018
By BioPharm International Editors
FDA awarded nearly $3 million in grants for continuous manufacturing and other advanced manufacturing technologies as part of the agency’s efforts to ensure a robust and reliable supply of biological products.
Sep 20, 2018
By BioPharm International Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Aug 09, 2018
By BioPharm International Editors
The combined companies will provide research- and clinical-grade human immune cells, blood products, and related services.
Aug 08, 2018
By BioPharm International Editors
Avalon and Weill will co-develop bio-production and standardization procedures for CAR-T therapy.
Aug 06, 2018
By BioPharm International Editors
Boehringer Ingelheim joins Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene therapy to treat cystic fibrosis.
Aug 06, 2018
By BioPharm International Editors
The companies will collaborate on the discovery, development, and commercialization of cell therapies for cancer.
native1_300x100
lorem ipsum